Litcius/Paper detail

Phase II study of pembrolizumab efficacy and safety in women with recurrent small cell neuroendocrine carcinoma of the lower genital tract

Michael Frumovitz, Shannon N. Westin, Gloria Salvo, Abdulrazzak Zarifa, Mingxuan Xu, Timothy A. Yap, Ahnert J. Rodon, Daniel D. Karp, Abdulrahman Abonofal, Amir A. Jazaeri, Aung Naing

2020Gynecologic Oncology70 citationsDOIOpen Access PDF

Topics & Concepts

MedicinePembrolizumabAsymptomaticInternal medicineAdverse effectClinical endpointGastroenterologyCarcinomaSurgeryOncologyClinical trialCancerImmunotherapyNeuroendocrine Tumor Research AdvancesLung Cancer Research StudiesChromatin Remodeling and Cancer